Drug
Dhea (dehydroepiandrosterone)
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Sleep Apnoea Syndrome | 27 | 15.5 | 15.7 | signal |
| 2 | Thyroid Disorder | 15 | 10.7 | 10.8 | signal |
| 3 | Fibromyalgia | 21 | 9.5 | 9.6 | signal |
| 4 | Malignant Melanoma | 11 | 9.0 | 9.1 | signal |
| 5 | Bursitis | 9 | 8.2 | 8.2 | signal |
| 6 | Ligament Sprain | 7 | 7.8 | 7.8 | signal |
| 7 | Nocturia | 8 | 7.3 | 7.3 | signal |
| 8 | Therapeutic Response Unexpected | 27 | 6.6 | 6.7 | signal |
| 9 | Adrenal Insufficiency | 7 | 6.4 | 6.4 | signal |
| 10 | Carpal Tunnel Syndrome | 8 | 6.3 | 6.3 | signal |
| 11 | Blood Thyroid Stimulating Hormone Increased | 5 | 6.0 | 6.0 | signal |
| 12 | Erectile Dysfunction | 13 | 5.5 | 5.6 | signal |
| 13 | Vaginal Discharge | 5 | 5.5 | 5.5 | signal |
| 14 | Gastroenteritis Viral | 9 | 5.5 | 5.5 | signal |
| 15 | Musculoskeletal Discomfort | 8 | 5.1 | 5.1 | signal |
| 16 | Hunger | 6 | 4.9 | 4.9 | signal |
| 17 | Nerve Compression | 4 | 4.8 | 4.8 | signal |
| 18 | Increased Tendency To Bruise | 4 | 4.8 | 4.8 | signal |
| 19 | Mental Impairment | 10 | 4.5 | 4.5 | signal |
| 20 | Vitreous Floaters | 4 | 4.5 | 4.5 | signal |
| 21 | Brain Injury | 4 | 4.4 | 4.4 | signal |
| 22 | Sluggishness | 4 | 4.3 | 4.3 | signal |
| 23 | Ear Discomfort | 4 | 4.3 | 4.3 | signal |
| 24 | Pelvic Pain | 7 | 4.2 | 4.2 | signal |
| 25 | Body Height Decreased | 4 | 4.1 | 4.1 | signal |
| 26 | Back Disorder | 6 | 4.0 | 4.0 | signal |
| 27 | Tooth Disorder | 8 | 3.9 | 3.9 | signal |
| 28 | Unevaluable Event | 27 | 3.9 | 4.0 | signal |
| 29 | Metrorrhagia | 6 | 3.8 | 3.8 | signal |
| 30 | Paranoia | 6 | 3.8 | 3.8 | signal |
| 31 | Systemic Lupus Erythematosus | 12 | 3.7 | 3.7 | signal |
| 32 | Spinal Operation | 4 | 3.6 | 3.6 | signal |
| 33 | No Therapeutic Response | 4 | 3.6 | 3.6 | signal |
| 34 | Tendon Rupture | 4 | 3.6 | 3.6 | signal |
| 35 | Libido Decreased | 4 | 3.5 | 3.6 | signal |
| 36 | Muscle Spasticity | 4 | 3.5 | 3.6 | signal |
| 37 | Tendonitis | 5 | 3.5 | 3.5 | signal |
| 38 | Application Site Irritation | 4 | 3.5 | 3.5 | signal |
| 39 | Injection Site Extravasation | 4 | 3.5 | 3.5 | signal |
| 40 | Gastric Disorder | 11 | 3.5 | 3.5 | signal |
| 41 | Injection Site Induration | 4 | 3.4 | 3.4 | signal |
| 42 | Rash Generalised | 8 | 3.3 | 3.4 | signal |
| 43 | Crying | 11 | 3.3 | 3.3 | signal |
| 44 | Central Nervous System Lesion | 4 | 3.2 | 3.2 | no signal |
| 45 | Prostatic Specific Antigen Increased | 4 | 3.2 | 3.2 | no signal |
| 46 | Local Swelling | 5 | 3.1 | 3.1 | signal |
| 47 | Anosmia | 4 | 3.0 | 3.0 | no signal |
| 48 | Application Site Pruritus | 6 | 2.9 | 2.9 | signal |
| 49 | Suicidal Ideation | 24 | 2.9 | 2.9 | signal |
| 50 | Drug Prescribing Error | 5 | 2.8 | 2.8 | signal |
| 51 | Abnormal Dreams | 7 | 2.8 | 2.8 | signal |
| 52 | Activities Of Daily Living Impaired | 5 | 2.7 | 2.7 | no signal |
| 53 | Wrong Technique In Drug Usage Process | 9 | 2.7 | 2.7 | signal |
| 54 | Abasia | 6 | 2.6 | 2.6 | signal |
| 55 | Dysmenorrhoea | 3 | 2.5 | 2.5 | no signal |
| 56 | Drug Administration Error | 7 | 2.5 | 2.5 | signal |
| 57 | Product Substitution Issue | 12 | 2.3 | 2.3 | signal |
| 58 | Menorrhagia | 4 | 2.2 | 2.2 | no signal |
| 59 | Product Physical Issue | 4 | 2.2 | 2.2 | no signal |
| 60 | Vaginal Haemorrhage | 8 | 2.1 | 2.1 | no signal |
| 61 | Acne | 14 | 2.0 | 2.0 | signal |
| 62 | Plasma Cell Myeloma | 7 | 2.0 | 2.0 | no signal |
| 63 | Injection Site Reaction | 12 | 1.9 | 1.9 | no signal |
| 64 | Product Adhesion Issue | 6 | 1.9 | 1.9 | no signal |
| 65 | Inappropriate Schedule Of Drug Administration | 12 | 1.8 | 1.8 | no signal |
| 66 | Product Administered At Inappropriate Site | 3 | 1.8 | 1.8 | no signal |
| 67 | Injection Site Urticaria | 4 | 1.8 | 1.8 | no signal |
| 68 | Incorrect Dose Administered By Device | 4 | 1.7 | 1.7 | no signal |
| 69 | Menstruation Irregular | 4 | 1.7 | 1.7 | no signal |
| 70 | Injection Site Mass | 5 | 1.5 | 1.5 | no signal |
| 71 | Injection Site Rash | 4 | 1.4 | 1.4 | no signal |
| 72 | Device Issue | 11 | 1.4 | 1.4 | no signal |
| 73 | Abortion Spontaneous | 5 | 1.4 | 1.4 | no signal |
| 74 | Injection Site Swelling | 9 | 1.3 | 1.3 | no signal |
| 75 | Application Site Erythema | 3 | 1.3 | 1.3 | no signal |
| 76 | Drug Withdrawal Syndrome | 10 | 1.2 | 1.2 | no signal |
| 77 | Injection Site Pruritus | 7 | 1.2 | 1.2 | no signal |
| 78 | Injection Site Haemorrhage | 8 | 1.1 | 1.1 | no signal |
| 79 | Gynaecomastia | 3 | 1.1 | 1.1 | no signal |
| 80 | Wrong Technique In Device Usage Process | 4 | 1.0 | 1.0 | no signal |